Wellington Management Group’s Audentes Therapeutics, Inc BOLD Stock Holding History

Wellington Management Group’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-622,011	Closed	-$37.2M	–	2144
2019 Q4	$37.2M	Sell	622,011 -2,167,563	-78%	-$81.4M	0.01%	836
2019 Q3	$78.4M	Sell	2,789,574 -145,359	-5%	-$4.96M	0.02%	603
2019 Q2	$111M	Sell	2,934,933 -414,538	-12%	-$15.9M	0.02%	533
2019 Q1	$131M	Sell	3,349,471 -31,599	-0.9%	-$906K	0.03%	483
2018 Q4	$72.1M	Buy	3,381,070 +77,668	+2%	+$2M	0.02%	605
2018 Q3	$131M	Sell	3,303,402 -40,325	-1%	-$1.5M	0.03%	495
2018 Q2	$128M	Sell	3,343,727 -816,241	-20%	-$30.2M	0.03%	502
2018 Q1	$125M	Buy	+4,159,968	New	+$141M	0.03%	502

Wellington Management Group's BOLD Position: Q1 2020 in Review

Wellington Management Group sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 622,011 shares — an estimated $37.2M sold.

Wellington Management Group first reported a position in BOLD in Q1 2018 and held it in 8 quarters. The position peaked at $131M in Q3 2018. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Wellington Management Group reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Wellington Management Group sold 622,011 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $37.2M.
Wellington Management Group first reported a position in Audentes Therapeutics, Inc in Q1 2018 and held it in 8 quarters.
Wellington Management Group's Audentes Therapeutics, Inc position peaked at $131M in Q3 2018.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Wellington Management Group's 13F filing for Q1 2020, filed 14 May 2020.